Grocery Manufacturers Association, Washington, DC, USA.
Appl Environ Microbiol. 2011 Feb;77(4):1171-80. doi: 10.1128/AEM.01564-10. Epub 2010 Dec 17.
Internalin A (InlA; encoded by inlA) facilitates the crossing of the intestinal barrier by Listeria monocytogenes. Mutations leading to a premature stop codon (PMSC) in inlA and thus attenuated mammalian virulence have been reported. We recently characterized 502 L. monocytogenes food isolates from a retail survey and 507 human clinical isolates from multiple U.S. states with respect to the presence/absence of inlA mutations. The objective of this study was to investigate the hypothesis that dose responses for human listeriosis vary between L. monocytogenes strains with and those without a PMSC in inlA. Subtype-specific prevalence and concentration distributions in food, along with epidemiologic and consumption data, were input into established dose-response models to generate an r value (probability of a cell causing illness). Under the conservative assumption that L. monocytogenes levels at retail represent levels consumed, mean log(10) r values were -8.1 and -10.7 for L. monocytogenes subtypes with genes encoding a full-length and a truncated InlA, respectively. L. monocytogenes carrying a 5' frameshift mutation in a homopolymeric tract showed a mean log(10) r value of -12.1. Confidence intervals for the r values and their differences varied depending on subtypes. When the increase in concentration of L. monocytogenes subtypes between retail and consumption was considered, mean log(10) r values were reduced to -10.4, -13.8, and -12.8 for the subtypes with genes encoding a full-length InlA, for the subtypes carrying a PMSC in inlA, and for all L. monocytogenes isolates regardless of subtype, respectively. Our study provides further quantitative evidence that L. monocytogenes subtypes vary in abilities and relative likelihoods of causing human disease, which were mechanistically related to defined genetic markers.
InlA(由 inlA 编码)有助于单核细胞增生李斯特菌穿过肠道屏障。已经报道了导致 inlA 中提前出现终止密码子(PMSC)从而减弱哺乳动物毒力的突变。我们最近对来自零售调查的 502 株单核细胞增生李斯特菌食品分离株和来自美国多个州的 507 株人类临床分离株进行了研究,以确定 inlA 突变的存在/缺失情况。本研究的目的是验证以下假设:有无 PMSC 的 inlA 缺失的单核细胞增生李斯特菌菌株之间的人类李斯特菌病剂量反应是否存在差异。食品中亚型特异性的流行率和浓度分布,以及流行病学和消费数据,被输入到已建立的剂量反应模型中,以生成 r 值(细胞引起疾病的概率)。在零售水平的单核细胞增生李斯特菌水平代表消费水平的保守假设下,分别具有全长和截断 InlA 编码基因的单核细胞增生李斯特菌亚型的平均对数(10)r 值为-8.1 和-10.7。在同聚核苷酸序列中发生 5'移码突变的单核细胞增生李斯特菌显示出平均对数(10)r 值为-12.1。r 值及其差异的置信区间因亚型而异。当考虑到零售和消费之间单核细胞增生李斯特菌亚型浓度的增加时,具有全长 InlA 编码基因的亚型的平均对数(10)r 值分别降低至-10.4、-13.8 和-12.8,而具有 inlA 中的 PMSC 的亚型的 r 值分别降低至-10.4、-13.8 和-12.8,以及所有单核细胞增生李斯特菌分离株,无论亚型如何,r 值分别降低至-10.4、-13.8 和-12.8。我们的研究提供了进一步的定量证据,表明单核细胞增生李斯特菌亚型在引起人类疾病的能力和相对可能性方面存在差异,这与明确的遗传标记有关。